Skip to product information
1 of 1


HeadaTerm 2 Electrode (3-pack)

HeadaTerm 2 Electrode (3-pack)

Regular price $39.99
Regular price $59.99 Sale price $39.99
Sale Sold out
Shipping calculated at checkout.

Use only with HeadaTerm® 2 device.

It is important to cleanse your skin before every HeadaTerm® 2 session.

This will help ensure the electrode attaches securely to your forehead


View full details
sale up to 30% off

Exclusive Pre-sale for HeadaTerm 2!

Act fast! Only 30 pre-sale slots available – reserve yours now!

Pre-sale Discount Code: PREHT30

eTNS Technology

The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device

Success Rate

HeadaTerm 2 delivers targeted electrical impulses to increase the user's pain tolerance.

* Data source based on over 1000 user tests

Up to 27% more effective than oral medicine

Published by Emegency Medicine in the United States

Learn More
PrincipleeTNS technology
IndicationsThe TENS device-HeadaTerm 2 is indicated for the prophylactic treatment of episodic migraine in patients 18 years of age or older.
CertificateFDA, CE, TGA, HC, ISO

For every HeadaTerm 2 Anti-migraine Device purchased, $1 will be donated to VHA Headache Centers

*Donate every 5 months and publish the donation voucher

Learn more


100% secure checkout

30 Days Money Back Guarantee

1-year warranty guarantee

Worldwide Shipping

Fast delivery available

Free Shipping on All Orders Over $30

Multi-country transfer within 5-7 days

Relieve Migraine Without Medication


100% Drug-Free

Easy Operation

Quick Effect

New Generation Of Targeted Thrapeutic Anti-Migraine Device

Primary headaches are debilitating conditions that are extremely common among people. Drug treatments are the popular solutions for many patients, but just like with anti-nausea drugs, there are side effects that often turn people away. HeadaTerm offers a drug-free treatment without any side effects.

More advanced than HeadaTerm Generation 1.


How to use

Learn more

One-button control

  • The one-button control feature simplifies the operation of the device, allowing users to easily toggle the on/off switch and adjust the intensity of the nine electric stimulation gears using a single button on the main unit.

Compact And Easy To Carry

  • The standard package contains the device main body, 3 pieces of electrodes, a storage bag, a charging cable, a manual, and auxiliary straps.

HeadaTerm 2 Electrode (3-pack)



Primary headaches, such as migraine, are transmitted by the supraorbital nerve and the supratrochlear nerve. HeadaTerm introduces precise electric impulses from the user’s forehead to act on these nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users. Every device contains 21 rounds of standard therapies, each therapy lasts 20 minutes.


HeadaTerm Official Sustainability Plan

Every 5 used devices can be exchanged for 1 new device.

Learn More

EmeTerm® HeadaTerm Testimonials

Customers Testimonials


  • Hokenek N M, Erdogan M O, Hokenek U D, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial[J]. The American Journal of Emergency Medicine, 2021, 39: 80-85.
  • Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003 Apr;4(3):109-21.
  • Shealy CN. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. J Altern Complement Med. 2003 Oct;9(5):619-23.
  • Huang W, Kutner N, Bliwise DL. Autonomic activation in insomnia: the case for acupuncture. J Clin Sleep Med. 2011 Feb 15;7(1):95-102.
  • Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatr Clin North Am. 2013 Mar;36(1):169-76.
  • Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013 Feb 19;80(8):697-704.
  • Nihat M. Hokenek, MD. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomized controlled trial. VOLUME 39, P80-85, JANUARY 01, 2021